Skip to main content
Clinical Trials/NCT05117307
NCT05117307
Not yet recruiting
Not Applicable

Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section

Erzurum Regional Training & Research Hospital1 site in 1 country60 target enrollmentDecember 20, 2025

Overview

Phase
Not Applicable
Intervention
Bupivacaine 0.25% Injectable Solution
Conditions
Pain
Sponsor
Erzurum Regional Training & Research Hospital
Enrollment
60
Locations
1
Primary Endpoint
Opioid Consumption
Status
Not yet recruiting
Last Updated
4 months ago

Overview

Brief Summary

Cesarean section is one of the most common major surgical procedures performed worldwide,, Post-cesarean analgesia should provide adequate pain control while allowing the mother to remain active to meet the needs of the baby. Insufficient analgesia after cesarean section may be associated with acute postoperative pain, chronic pain, higher opioid consumption, delayed functional capacity, and postpartum depression. Techniques such as neuraxial techniques, oral and intravenous agents, wound infiltration, and behavioral therapy can be used in the treatment of post-cesarean pain pain. In addition, Transversus abdominis plane block (TAP), Quadratus Lumborum block (QLB), Erector Spina block (ESP), Transversalis Fascia plane block (TFP) are used safely under ultrasound guidance. In this study, it was aimed primarily to examine the effects of TFP and ESP blocks on pain scores, and secondarily to evaluate analgesic consumption.

Registry
clinicaltrials.gov
Start Date
December 20, 2025
End Date
June 30, 2026
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Erzurum Regional Training & Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Omer Doymus

Medical Doctor

Erzurum Regional Training & Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Between 18-50 years
  • Cesarean Section

Exclusion Criteria

  • Cesarean Section under general anesthesia
  • emergency cases
  • those with a body mass index greater than 35 kg/m2
  • coagulopathy
  • local infection

Arms & Interventions

Group ESP

Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine, per side

Intervention: Bupivacaine 0.25% Injectable Solution

Group TFP

Ultrasound-guided Transversalis Fascia Plane Block block with 20 ml %0.25 bupivacaine, per side

Intervention: Bupivacaine 0.25% Injectable Solution

Outcomes

Primary Outcomes

Opioid Consumption

Time Frame: Postoperative first 24 hours

Opioid consumption postroperative period

Secondary Outcomes

  • Visual Analog Pain Score(Postoperative first 24 hours)

Study Sites (1)

Loading locations...

Similar Trials